rss
Help

Neglected disease research and development: how much are we really spending

5168 views
|
DOI: 10.4016/9649.01
|
login to rate  
URL
Embed
| More
  1. Hotez P, Molyneux DH, Fenwich A, Kumaresan J, Sachs SE (2007) Control of neglected tropical diseases. N Engl J Med 357: 1018-1026.
  2. Toreele E, Usdin M, Chirac P (2004) A needs-based pharmaceutical R&D agenda for neglected diseases. World Health Organization: 12Available: http://www.who.int/intellectualproperty/topics/research/Needs%20based%20R&D%20for%20neglected%20diseases%20Els%20Pierre%20Martine.pdf. Accessed 30 December 2008.
  3. IJsselmuiden C, de Haan S, Iacono SL, Kisia CN, Moomal H (2008) Alignment and harmonisation in health research: AHA study. Council for Health Research for Development: 29-39Available: http://www.cohred.org/AHA/files/resources/Synthesis_web.pdf. Accessed 30 December 2008.
  4. Currat LJ, de Francisco A, Al-Tuwaijri S, Ghaffar A, Jupp S (2004) Progress in measuring the 10/90 gap. Global Forum for Health Research: 107-126Available: http://www.globalforumhealth.org/filesupld/1090_report_03_04/109004_chap_5.pdf. Accessed 30 December 2008.
  5. (2008) Sustaining the HIV prevention research agenda: Funding for research and development of HIV vaccines, microbicides, and other new prevention options 2000–2007: 1-38Available: http://hivresourcetracking.org/content/RT_report_August2008.pdf. Accessed 30 December 2008.
  6. Feuer C (2007) . Tuberculosis research and development: A critical analysis of funding trends, 2005–2006Treatment Action Group. New York.
  7. (2005) Malaria research & development: An assessment of global investment. Program for Appropriate Technology in Health: 1-53Available: http://www.malariavaccine.org/files/MalariaRD_Report_complete.pdf. Accessed 30 December 2008.
  8. (2001) Macroeconomics and health: Investing in health for economic development. Report of the Commission on Macroeconomics and Health: 89Available: http://whqlibdoc.who.int/publications/2001/924154550x.pdf. Accessed 30 December 2008.
  9. (2008) Diseases covered by NTD departmentAvailable: http://www.who.int/neglected_diseases/diseases/en/. Accessed 30 December 2008.
  10. (2008) Overview on diseasesAvailable: http://www.who.int/tdr/svc/diseases. Accessed 30 December 2008.
  11. (2008) The seven most common NTDsAvailable: http://gnntdc.sabin.org/about-ntds/factsheets. Accessed 30 December 2008.
  12. (2005) A new era of hope for the world's most neglected diseases. PLoS Med 2: e323doi:10.1371/journal.pmed.0020323.
  13. (2002) National Institutes of Health Fiscal Year 2002 Plan for HIV-Related Research USA 5–266.
  14. Anderson J, MacLean M, Davies C (1996) Malaria research—An audit of international activity. PRISM (Unit for Policy Research in Science and Medicine) UK Report 7: 1-96.
  15. (2007) IMF exchange rates databaseAvailable: http://www.imf.org/external/np/fin/ert/GUI/Pages/CountryDataBase.aspx. Accessed 7 December 2007.
  16. (2007) Main science and technology indicators databaseAvailable: http://lysander.sourceoecd.org/vl=3010314/cl=12/nw=1/rpsv/cw/vhosts/oecdstats/16081242/v207n1/contp1-1.htm. Accessed 7 December 2007.
  17. (2008) The global burden of disease: 2004 updateAvailable: http://www.who.int/healthinfo/global_burden_disease/2004_report_update/en/index.html. Accessed 30 December 2008.
  18. Moran M, Guzman J, Ropars A, Jorgensen M, McDonald A (2007) The malaria product pipeline: Planning for the future. The George Institute for International HealthAvailable: http://www.thegeorgeinstitute.org/shadomx/apps/fms/fmsdownload.cfm?file_uuid=1ABDE79C-DA73-20B3-D6E1-F7AF25011EC9&siteName=iih. Accessed 30 December 2008.
Please describe the reason for abuse:
Supplementary Materials
Comments